LGR5 and acute lymphoblastic leukemia: Interestingly, in the same time window REH cells, a preB-ALL line with low expression of LGR5, was not targeted by LGR5scFv-CAR-NK92 cells indicating that a safe therapeutic window could be achieved for the LGR5scFv-CAR (Appendix Fig. S6B).